XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$19.84
-0.08 (-0.40%)
As of Aug 8, 1:43 AM ET ·
Financial Highlights (FY 2026)
Revenue
126.42M
Net Income
-92,542,456
Gross Margin
Profit Margin
-73.2%
Rev Growth
-8.6%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 126.42M 138.36M 205.11M 207.84M
Gross Profit 124.21M 125.86M
Operating Income -187,926,115 -185,108,354 -10,389,491 -11,650,007
Net Income -92,542,456 -91,154,876 -12,900,416 -11,029,247
Gross Margin 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Rev Growth -8.6% -8.6% +24.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 117.54M 117.54M 77.39M 67.20M
Total Equity 623.88M 623.88M 595.63M 536.70M
D/E Ratio 0.19 0.19 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -177,349,373 -184,395,211 -15,864,221 -15,646,651
Free Cash Flow -6,278,593 -9,889,518